Enolase deficiency: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Enolase deficiency | |||
| synonyms = Glycolytic enzymopathy | |||
| field = [[Neurology]], [[Genetics]] | |||
| symptoms = [[Muscle weakness]], [[Exercise intolerance]], [[Cramps]], [[Myalgia]] | |||
| onset = [[Childhood]] or [[Adolescence]] | |||
| duration = [[Chronic]] | |||
| causes = [[Genetic mutation]] in the [[ENO3]] gene | |||
| risks = [[Family history]] of the condition | |||
| diagnosis = [[Genetic testing]], [[Muscle biopsy]], [[Enzyme assay]] | |||
| differential = [[Other glycolytic enzymopathies]], [[Muscular dystrophy]] | |||
| treatment = [[Supportive care]], [[Physical therapy]], [[Avoidance of strenuous exercise]] | |||
| prognosis = [[Variable]], depending on severity | |||
| frequency = [[Rare]] | |||
}} | |||
- Enolase Deficiency is a rare genetic disorder of glucose metabolism. Partial deficiencies have been observed in several caucasian families. The deficiency is transmitted through an autosomal dominant inheritance pattern. The for Enolase 1 has been localized to Chromosome 1 in humans. Enolase deficiency, like other glycolytic enzyme deficiences, usually manifests in red blood cells as they rely entirely on anaerobic glycolysis. Enolase deficiency is associated with a spherocytic phenotype and can result in hemolytic anemia, which is responsible for the clinical signs of Enolase deficiency. | |||
[[Category:Uncategorized | [[Category:Uncategorized | ||
{{stb}} | {{stb}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 03:17, 4 April 2025
| Enolase deficiency | |
|---|---|
| Synonyms | Glycolytic enzymopathy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, Exercise intolerance, Cramps, Myalgia |
| Complications | N/A |
| Onset | Childhood or Adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in the ENO3 gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, Muscle biopsy, Enzyme assay |
| Differential diagnosis | Other glycolytic enzymopathies, Muscular dystrophy |
| Prevention | N/A |
| Treatment | Supportive care, Physical therapy, Avoidance of strenuous exercise |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
- Enolase Deficiency is a rare genetic disorder of glucose metabolism. Partial deficiencies have been observed in several caucasian families. The deficiency is transmitted through an autosomal dominant inheritance pattern. The for Enolase 1 has been localized to Chromosome 1 in humans. Enolase deficiency, like other glycolytic enzyme deficiences, usually manifests in red blood cells as they rely entirely on anaerobic glycolysis. Enolase deficiency is associated with a spherocytic phenotype and can result in hemolytic anemia, which is responsible for the clinical signs of Enolase deficiency.
[[Category:Uncategorized
| This article is a stub. You can help WikiMD by registering to expand it. |
